Tripathi Shanshank, Pande Shantanu, Malhotra Pulkit, Mahindru Supaksh, Thukral Ankit, Kotwal Ankush Singh, Majumdar Gauranga, Agarwal Surendra Kumar, Gupta Amit
Department of Cardiovascular and Thoracic Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Indian J Thorac Cardiovasc Surg. 2020 Mar;36(2):127-133. doi: 10.1007/s12055-019-00856-5. Epub 2019 Sep 5.
Acute renal failure is a serious complication following cardiac surgery. This may lead to fatal outcome if not treated timely. Continuous renal replacement therapy (RRT) has shown improvement in outcome. There is no clear consensus on the timing of the initiation of RRT in these patients. This study evaluates the factors predicting favourable outcome in this group of patients.
Patients undergoing cardiac surgery between January 2015 and December 2018 are included in this retrospective study. RRT is required in 24 patients out of 2254 operated during this period. Patients are divided into groups, survivors (group 1, = 8) and dead (group 2, = 16). The preoperative information is accessed from the hospital information system and intensive care unit data. Multivariate analysis of pre continuous renal replacement therapy (CRRT) bicarbonate level, pH, potassium, time of initiating CRRT and central venous pressure is performed.
The incidence of acute renal failure requiring RRT is 1.06%. Patients in two groups were similar in demographics and presence of risk factors. There was difference in the pre RRT bicarbonate level ( = 0.007). On multivariate analysis, pre RRT bicarbonate levels predict survival ( = 0.003). ROC curve for pre RRT bicarbonate predicts survival for value above 16.83 mg/dl with 80% sensitivity and 78.6% specificity.
Bicarbonate level in blood predicts the best evidence for initiating the renal replacement therapy in of acute renal failure following cardiac surgery. When urine output drops to < 0.5 ml/kg and not responding to infusion of furosemide, RRT must be initiated at sodium bicarbonate in blood above 16.9 mg%.
急性肾衰竭是心脏手术后的一种严重并发症。若不及时治疗,可能导致致命后果。持续肾脏替代治疗(RRT)已显示出可改善预后。对于这些患者开始RRT的时机,目前尚无明确共识。本研究评估了预测该组患者良好预后的因素。
本回顾性研究纳入了2015年1月至2018年12月期间接受心脏手术的患者。在此期间接受手术的2254例患者中有24例需要RRT。患者分为两组,存活组(第1组,n = 8)和死亡组(第2组,n = 16)。术前信息从医院信息系统和重症监护病房数据中获取。对连续肾脏替代治疗(CRRT)前的碳酸氢盐水平、pH值、钾、开始CRRT的时间和中心静脉压进行多变量分析。
需要RRT的急性肾衰竭发生率为1.06%。两组患者在人口统计学和危险因素方面相似。RRT前的碳酸氢盐水平存在差异(P = 0.007)。多变量分析显示,RRT前的碳酸氢盐水平可预测生存率(P = 0.003)。RRT前碳酸氢盐的ROC曲线预测,当值高于16.83mg/dl时,生存率的敏感性为80%,特异性为78.6%。
血液中的碳酸氢盐水平是心脏手术后急性肾衰竭开始肾脏替代治疗的最佳证据。当尿量降至<0.5ml/kg且对呋塞米输注无反应时,必须在血液碳酸氢钠水平高于16.9mg%时开始RRT。